156
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Unexpected Pneumocystis jirovecii pneumonia in patients with untreated chronic lymphocytic leukemia

, , , , , , , , , , & show all
Pages 1004-1007 | Received 19 Dec 2016, Accepted 12 Jul 2017, Published online: 03 Aug 2017

References

  • Wadhwa PD, Morrison VA. Infectious complications of chronic lymphocytic leukemia. Semin Oncol. 2006;33:240–249.
  • Morrison VA. Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches. Best Pract Res. 2010;23:145–153.
  • Maertens J, Cesaro S, Maschmeyer G, et al. ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71:2397–2404.
  • Strich JR, Jerussi TD, Wiestner A, et al. Pneumocystis jirovecii Pneumonia in a Treatment-Naive Patient With Chronic Lymphocytic Leukemia. Infect Dis Clin Pract (Baltimore, Md.). 2016;24:e86–e87.
  • Kalkanis A, Judson MA, Napier MB. Pneumocystis jerovecii pneumonia in a patient with untreated chronic lymphocytic leukaemia: a novel case and postulations concerning the mechanism. BMJ Case Rep. 2013;2013. doi: 10.1136/bcr-2013-202124
  • Limper AH, Knox KS, Sarosi GA, et al. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011;183:96–128.
  • Rhew DC, Gaultier CR, Daar ES, et al. Infections in patients with chronic adult T-cell leukemia/lymphoma: case report and review. Clin Infect Dis. 1995;21:1014–1016.
  • Cordonnier C, Cesaro S, Maschmeyer G, et al. Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71:2379–2385.
  • Ahn IE, Jerussi T, Farooqui M, Tian X, Wiestner A, Gea-Banacloche J. Atypical Pneumocystis jirovecii pneumonia in previously untreated patients with CLL on single-agent ibrutinib. Blood. 2016;128:1940–1943.
  • Robak T. Emerging monoclonal antibodies and related agents for the treatment of chronic lymphocytic leukemia. Future Oncol. 2013;9:69–91.
  • Zent CS. CLL: an acquired immunodeficiency disease. Blood. 2016;128:1908–1909.
  • Tsiodras S, Samonis G, Keating MJ, et al. Infection and immunity in chronic lymphocytic leukemia. Mayo Clin Proc. 2000;75:1039–1054.
  • Scrivener S, Goddard RV, Kaminski ER, et al. Abnormal T-cell function in B-cell chronic lymphocytic leukaemia. Leuk Lymphoma. 2003;44:383–389.
  • Totterman TH, Carlsson M, Simonsson B, et al. T-cell activation and subset patterns are altered in B-CLL and correlate with the stage of the disease. Blood. 1989;74:786–792.
  • Catherinot E, Lanternier F, Bougnoux ME, et al. Pneumocystis jirovecii Pneumonia. Infect Dis Clin North Am. 2010;24:107–138.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.